Biegała Ł, Gajek A, Marczak A, Rogalska A. PARP inhibitor resistance in ovarian cancer: underlying mechanisms and therapeutic approaches targeting the ATR/CHK1 pathway. Biochim Biophys Acta Rev Cancer. 2021;1876(2):188633.

Article  PubMed  Google Scholar 

Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 2019;69(4):280–304.

PubMed  Google Scholar 

Forstner R. Early detection of ovarian cancer. Eur Radiol. 2020;30(10):5370–3.

Article  PubMed  PubMed Central  Google Scholar 

Pinton G, Nilsson S, Moro L. Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality. Oncogenesis. 2018;7(2):1–11.

Article  CAS  Google Scholar 

Yu X, Liang C, Zhang Y, Zhang W, Chen H. Inhibitory short peptides targeting EPS8/ABI1/SOS1 tri-complex suppress invasion and metastasis of ovarian cancer cells. BMC Cancer. 2019;19(1):1–12.

Article  Google Scholar 

Peng JM, Chen YH, Hung SW, Chiu CF, Ho MY, Lee YJ, et al. Recombinant viral protein promotes apoptosis and suppresses invasion of ovarian adenocarcinoma cells by targeting α5β1 integrin to down-regulate Akt and MMP-2. Br J Pharmacol. 2012;165(2):479–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Labidi-Galy SI, Papp E, Hallberg D, Niknafs N, Adleff V, Noe M, et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat Commun. 2017;8(1):1–11.

Article  CAS  Google Scholar 

Vang R, Shih IM, Kurman RJ. Fallopian tube precursors of ovarian low-and high-grade serous neoplasms. Histopathology. 2013;62(1):44–58.

Article  PubMed  Google Scholar 

Chene G, Lamblin G, Bail-Carval L, Chabert P, Bakrin N, Mellier G. Early preinvasive lesions in ovarian cancer. Biomed Res Int. 2014;2014:1–11

Gershenson DM. Low-grade serous carcinoma of the ovary or peritoneum. Ann Oncol. 2016;27:i45–9.

Article  PubMed  Google Scholar 

McGregor RJ, Chau Y-Y, Kendall TJ, Artibani M, Hastie N, Hadoke PW. WT1 expression in vessels varies with histopathological grade in tumour-bearing and control tissue from patients with breast cancer. Br J Cancer. 2018;119(12):1508–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Waehle V, Ungricht R, Hoppe PS, Betschinger J. The tumor suppressor WT1 drives progenitor cell progression and epithelialization to prevent Wilms tumorigenesis in human kidney organoids. Stem Cell Rep. 2021;16(9):2107–17.

Article  CAS  Google Scholar 

Santiago S-A, Pablo Z-B, Edgar M-G. Karina C-EA, Mariela A-R, Cristina R-P: truncated WT1 protein isoform expression is increased in MCF-7 cells with long-term estrogen depletion. Int J Breast Cancer. 2021;2021:1–9.

Hylander B, Repasky E, Shrikant P, Intengan M, Beck A, Driscoll D, et al. Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer. Gynecol Oncol. 2006;101(1):12–7.

Article  CAS  PubMed  Google Scholar 

Han Y, Song C, Zhang T, Zhou Q, Zhang X, Wang J, et al. Wilms’ tumor 1 (WT1) promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling. Cell Cycle. 2020;19(20):2662–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meng K, Cao J, Dong Y, Zhang M, Ji C, Wang X. Application of bioinformatics analysis to identify important pathways and hub genes in ovarian Cancer affected by WT1. Front Bioeng Biotechnol. 2021;9:1–14.

Niavarani A, Currie E, Reyal Y, Anjos-Afonso F, Horswell S, Griessinger E, et al. APOBEC3A is implicated in a novel class of G-to-a mRNA editing in WT1 transcripts. PLoS One. 2015;10(3):e0120089.

Article  PubMed  PubMed Central  Google Scholar 

Haber DA, Englert C, Maheswaran S. Functional properties of WT1. Med Pediatr Oncol. 1996;27(5):453–5.

Article  CAS  PubMed  Google Scholar 

Burwell E, McCarty G, Simpson L, Thompson K, Loeb D. Isoforms of Wilms’ tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells. Oncogene. 2007;26(23):3423–30.

Article  CAS  PubMed  Google Scholar 

Han Y, San-Marina S, Yang L, Khoury H, Minden MD. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells. Breast Cancer Res. 2007;9(4):1–13.

Article  Google Scholar 

Meng K, Wang X, He Y, Wang H, Xie X, Zhang Y, et al. Evidence that downregulation of Wilms’ tumor 1 (WT1) is involved in cortical stromal cell differentiation into theca cells in adult bovine ovaries. Mol Reprod Dev. 2019;86(11):1731–40.

Article  CAS  PubMed  Google Scholar 

Meng K, Wang X, He Y, Yang J, Wang H, Zhang Y, et al. The Wilms tumor gene (WT1)(+/− KTS) isoforms regulate steroidogenesis by modulating the PI3K/AKT and ERK1/2 pathways in bovine granulosa cells. Biol Reprod. 2019;100(5):1344–55.

Article  PubMed  Google Scholar 

Wang X, Meng K, Wang Y, Zhao Y, Lin F, Liu X, et al. Wilms' tumor (WT1)(±KTS) variants decreases the progesterone secretion of bovine ovarian theca cells. Domest Anim Endocrinol. 2021;74:106521.

Article  CAS  PubMed  Google Scholar 

Liu J, Yang G, Thompson-Lanza JA, Glassman A, Hayes K, Patterson A, et al. A genetically defined model for human ovarian cancer. Cancer Res. 2004;64(5):1655–63.

Article  CAS  PubMed  Google Scholar 

Auersperg N, Siemens CH, Myrdal SE. Human ovarian surface epithelium in primary culture. In Vitro. 1984;20(10):743–55.

Article  CAS  PubMed  Google Scholar 

Wu R, Zhai Y, Fearon ER, Cho KR. Diverse mechanisms of β-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res. 2001;61(22):8247–55.

CAS  PubMed  Google Scholar 

He S, Deng Y, Liao Y, Li X, Liu J, Yao S. CREB5 promotes tumor cell invasion and correlates with poor prognosis in epithelial ovarian cancer. Oncol Lett. 2017;14(6):8156–61.

PubMed  PubMed Central  Google Scholar 

Liu Y, Gao S, Zhu J, Zheng Y, Zhang H, Sun H. Dihydroartemisinin induces apoptosis and inhibits proliferation, migration, and invasion in epithelial ovarian cancer via inhibition of the hedgehog signaling pathway. Cancer Med. 2018;7(11):5704–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng L, Zhang K, Qing Y, Li D, Cui M, Jin P, et al. Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells. J Ovarian Res. 2020;13(1):1–13.

Article  Google Scholar 

Tanyi JL, Morris AJ, Wolf JK, Fang X, Hasegawa Y, Lapushin R, et al. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer. Cancer Res. 2003;63(5):1073–82.

CAS  PubMed  Google Scholar 

Scholz H, Kirschner KM. A role for the Wilms’ tumor protein WT1 in organ development. Physiology. 2005;20(1):54–9.

Article  CAS  PubMed  Google Scholar 

Wei L, Li P, Zhao C, Wang N, Wei N. Upregulation of microRNA-1270 suppressed human glioblastoma cancer cell proliferation migration and tumorigenesis by acting through WT1. OncoTargets Ther. 2019;12:4839.

Article  CAS  Google Scholar 

Du T, Zhang B, Zhang S, Jiang X, Zheng P, Li J, et al. Decreased expression of long non-coding RNA WT1-AS promotes cell proliferation and invasion in gastric cancer. Biochim Biophys Acta. 2016;1862(1):12–9.

Article  CAS  PubMed  Google Scholar 

Cui L, Nai M, Zhang K, Li L, Li R. lncRNA WT1-AS inhibits the aggressiveness of cervical cancer cell via regulating p53 expression via sponging miR-330-5p. Cancer Manag Res. 2019;11:651.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li B-Q, Liang Z-Y, Seery S, Liu Q-F, You L, Zhang T-P, et al. WT1 associated protein promotes metastasis and chemo-resistance to gemcitabine by stabilizing Fak mRNA in pancreatic cancer. Cancer Lett. 2019;451:48–57.

Article  CAS  PubMed  Google Scholar 

Potluri S, Assi SA, Chin PS, Coleman DJ, Pickin A, Moriya S, et al. Isoform-specific and signaling-dependent propagation of acute myeloid leukemia by Wilms tumor 1. Cell Rep. 2021;35(3):109010.

Article  CAS  PubMed  Google Scholar 

Potluri S, Assi SA, Chin SP, Ptasinska A, Coleman D, Cockerill P, et al. Isoform specific regulation of acute myeloid leukemia maintenance by Wilms tumor 1. Blood. 2019;134:1232.

Article  Google Scholar 

Wu CW, Hu W, Tian T. Endotoxins induced ECM-receptor interaction pathway signal effect on the function of MUC2 in Caco2/HT29 co-culture cells; 2022.

Book  Google Scholar 

Machackova T, Vychytilova-Faltejskova P, Souckova K, Trachtova K, Brchnelova D, Svoboda M, et al. MiR-215-5p reduces liver metastasis in an experimental model of colorectal cancer through regulation of ECM-receptor interactions and focal adhesion. Cancers. 2020;12(12):3518.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma F, Laster K, Nie W, Liu F, Kim DJ, Lee M-H, et al. Heterogeneity analysis of esophageal squamous cell carcinoma in cell lines, tumor tissues and patient-derived xenografts. J Cancer. 2021;12(13):3930.

Article